Migrating clinical studies to a new platform requires careful planning and is the focus of episode four in the Zelta Podcast series. We will be looking at the key considerations for migrating clinical studies.
Also covered are the reasons for and against a migration, the next step once a migration has been agreed upon, who builds the study, and what success looks like.
The guests are:
- Anjali Agrawal, Senior Life Sciences Consultant at Zelta by Merative
- Isaac Erickson, Vice President of Consulting Services at Zelta by Merative
Listen to the episode below:
To catch up on the three earlier episodes in the series, listen below:
